利润表（国际医学）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 3,606,256,924.42 | 2,420,461,714.17 | 1,172,923,244.52 | 4,617,873,479.43 | 3,343,661,725.08 | 2,209,788,795.81 | 1,059,092,457.42 |
| 营业收入(元) | 3,606,256,924.42 | 2,420,461,714.17 | 1,172,923,244.52 | 4,617,873,479.43 | 3,343,661,725.08 | 2,209,788,795.81 | 1,059,092,457.42 |
| 二、营业总成本(元) | 3,892,721,588.98 | 2,605,523,886.63 | 1,286,778,395.15 | 5,141,769,803.58 | 3,731,857,156.74 | 2,496,683,170.89 | 1,182,081,758.95 |
| 营业成本(元) | 3,274,876,374.70 | 2,190,858,912.92 | 1,081,008,638.98 | 4,177,035,768.63 | 3,048,279,680.34 | 2,038,310,879.08 | 972,385,400.75 |
| 研发费用(元) | 5,715,774.18 | 3,915,876.69 | 1,944,059.66 | 9,811,517.85 | 9,533,885.43 | 7,091,253.08 | 3,325,497.80 |
| 营业税金及附加(元) | 47,322,428.77 | 31,748,108.61 | 16,259,100.47 | 70,209,297.41 | 54,158,533.46 | 36,571,541.64 | 17,693,158.51 |
| 销售费用(元) | 19,025,093.80 | 11,459,986.38 | 611,800.83 | 41,427,674.82 | 22,384,372.09 | 14,488,868.36 | 664,059.91 |
| 管理费用(元) | 415,587,071.07 | 278,901,980.11 | 143,489,452.40 | 627,978,220.14 | 432,418,091.22 | 289,047,496.84 | 142,089,144.84 |
| 财务费用(元) | 130,194,846.46 | 88,639,021.92 | 43,465,342.81 | 215,307,324.73 | 165,082,594.20 | 111,173,131.89 | 45,924,497.14 |
| 其中：利息费用(元) | 130,933,373.00 | 90,621,009.43 | 45,969,808.24 | 219,033,108.83 | 169,729,410.18 | 113,615,519.36 | 50,039,603.75 |
| 其中：利息收入(元) | 6,228,860.17 | 5,495,859.92 | 4,546,172.89 | 9,502,772.05 | 7,269,449.75 | 4,697,980.45 | 3,036,234.16 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | -7,902,134.70 | -38,213,691.42 | -17,634,121.31 | 2,102,469.52 | 5,203,903.91 | 24,760,673.91 | 25,481,353.41 |
| 加：投资收益(元) | -1,003,915.95 | -670,272.92 | -327,052.85 | 71,762,260.79 | 119,835,383.00 | 2,184,722.89 | 64,115.65 |
| 其中：对联营企业和合营企业的投资收益(元) | -1,016,158.78 | -670,272.92 | -327,052.85 | -50,510,659.40 | -1,704,785.77 | -406,649.21 | -4,748.01 |
| 资产处置收益(元) | 303,928.99 | 304,499.79 | - | 1,950,645.60 | -83,031.59 | -83,031.59 | - |
| 信用减值损失(元) | -3,543,284.95 | -478,050.72 | 678,248.16 | -21,676,516.18 | -16,173,111.86 | -12,649,691.49 | - |
| 其他收益(元) | 15,203,655.54 | 3,054,678.60 | 2,693,150.54 | 7,735,425.88 | 2,871,232.38 | 2,435,313.56 | 2,233,810.05 |
| 四、营业利润(元) | -283,406,415.63 | -221,065,009.13 | -128,444,926.09 | -462,022,038.54 | -276,541,055.82 | -270,246,387.80 | -95,210,022.42 |
| 加：营业外收入(元) | 617,062.66 | 257,213.99 | 219,130.17 | 2,055,763.01 | 1,071,465.67 | 836,091.89 | 215,609.36 |
| 减：营业外支出(元) | 694,555.70 | - | 256,107.02 | 7,288,085.11 | 7,448,987.87 | 2,047,580.30 | 602,204.77 |
| 五、利润总额(元) | -283,483,908.67 | -220,807,795.14 | -128,481,902.94 | -467,254,360.64 | -282,918,578.02 | -271,457,876.21 | -95,596,617.83 |
| 减：所得税费用(元) | 10,788,863.23 | 8,017,011.94 | 3,395,197.98 | 4,694,444.63 | 312,893.36 | 165,057.17 | 142,932.43 |
| 六、净利润(元) | -294,272,771.90 | -228,824,807.08 | -131,877,100.92 | -471,948,805.27 | -283,231,471.38 | -271,622,933.38 | -95,739,550.26 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | -294,272,771.90 | -228,824,807.08 | -131,877,100.92 | -554,893,656.69 | -366,047,313.76 | -243,267,215.39 | -82,748,249.60 |
| 终止经营净利润(元) | - | - | - | 82,944,851.42 | 82,815,842.37 | -28,355,717.99 | -12,991,300.66 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | -212,108,983.83 | -173,605,843.66 | -104,912,277.28 | -368,360,645.24 | -222,323,554.29 | -222,259,756.80 | -74,740,547.17 |
| 少数股东损益(元) | -82,163,788.07 | -55,218,963.42 | -26,964,823.64 | -103,588,160.03 | -60,907,917.09 | -49,363,176.58 | -20,999,003.09 |
| 扣除非经常性损益后的净利润(元) | -219,532,355.14 | -138,904,605.89 | -89,849,571.13 | -499,002,182.75 | -349,572,337.62 | -254,885,965.65 | -103,333,541.03 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | -0.10 | -0.08 | -0.05 | -0.16 | -0.10 | -0.10 | -0.03 |
| 二、稀释每股收益(元) | -0.10 | -0.08 | -0.05 | -0.16 | -0.08 | -0.09 | -0.03 |
| 九、综合收益总额(元) | -294,272,771.90 | -228,824,807.08 | -131,877,100.92 | -471,948,805.27 | -283,231,471.38 | -271,622,933.38 | -95,739,550.26 |
| 归属于母公司所有者的综合收益总额(元) | -212,108,983.83 | -173,605,843.66 | -104,912,277.28 | -368,360,645.24 | -222,323,554.29 | -222,259,756.80 | -74,740,547.17 |
| 归属于少数股东的综合收益总额(元) | -82,163,788.07 | -55,218,963.42 | -26,964,823.64 | -103,588,160.03 | -60,907,917.09 | -49,363,176.58 | -20,999,003.09 |
| 公告日期 | 2024-10-25 | 2024-08-28 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-24 | 2023-04-19 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| 终止经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 42 of 42 entries